2013年4月9日,国家食品药品监督管理总局局长张勇主持召开会议,研究部署应对人感染H7N9禽流感疫情有关工作。他表示,针对近期出现的人感染H7N9禽流感疫情,我局迅速部署、积极应对。一方面,采取早期介入研发、加强沟通与指导等措施,在确保安全有效的前提下,加快相关防控药品的审批和上市。4月5日,已批准了新型抗流感病毒药物帕拉 April 9, 2013, State Food and Drug Administration Zhang Yong presided over a meeting to study the deployment of response to human infection with the H7N9 bird flu outbreak of the work. He said that in the light of the recent outbreak of human infection with H7N9, our bureau has quickly deployed and responded positively. On the one hand, measures such as early intervention in research and development, and enhanced communication and guidance should be adopted to speed up the approval and listing of relevant anti-control drugs under the premise of ensuring safety and effectiveness. On April 5, the new anti-influenza virus drug Para was approved